FutureMeds Congratulates Ninon Armbrust on BVMA Board Appointment

Prior to its 33rd Symposium, the Federal Association of Contract Research Organisations (BVMA e.V.) in Germany announced the election of the new Board. Ninon Armbrust, Managing Director of FutureMeds Germany, has been elected unanimously to the board. 

In the lead-up to its 33rd Symposium in Munich, which regularly gathers more than 300 stakeholders from research institutions, industry, regulatory bodies, and ethics committees, the Federal Association of Contract Research Organisations (Bundesverband Medizinischer Auftragsinstitute BVMA e.V.) announced the election of the new Board.  FutureMeds is pleased to share that Ninon Armbrust, Managing Director of FutureMeds Germany, has been elected to serve as Board Member. 

“Thank you Yvonne for the wonderful 8 years of cooperation. It has always been precious, fun, intense and we will miss you. But we also have good news - we have expanded the board to four people and now welcome Martin Krauss from FGK Clinical Research GmbH as chairman, Ralf Freese as vice-chairman, Ninon Armbrust from FutureMeds and Dr. Marc Rohde from IQVIA as additional board members. We are looking forward to the cooperation and the breath of fresh air in the BVMA board team.” 

- Official BVMA Announcement 

BVMA’s Role in Germany  

The BVMA, representing 51 companies active in national and international clinical development, plays a central role in shaping Germany’s clinical research environment. Since its founding in 1991, the association has become a significant stakeholder in regulatory and policy discussions, including its long-standing participation in national working groups and its membership in EUCROF, where it contributes German perspectives to European-level initiatives. 

In recent years, the association has been notably active in the development of the Medical Research Act (Medizinforschungsgesetz). Its contributions, ranging from formal position papers to coordinated statements through the Initiative Studienstandort Deutschland, have focused on ensuring that proposed regulations are not only legally robust but also operationally feasible.  

These efforts align with a broader sector-wide goal: reducing administrative barriers, improving approval timelines, and strengthening Germany’s attractiveness as a clinical research location.  

“Policy is strongest when it’s informed by people who’ve been close to the work. Ninon’s career, built at the study site, with teams, with patients, gives her a rare operational understanding. While her Board role is fully independent, I know her perspective will be a valuable addition to the BVMA’s work and to the wider German research community.”  

- Wojciech Szczepanik, Executive VP, Site Operations 

Ninon Armbrust's contribution to BVMA 

Ninon’s professional experience spans the full spectrum of clinical study operations. She began her career as a study nurse, later managed complex trial portfolios as a study coordinator, and went on to lead one of Germany’s largest dedicated research sites before assuming national leadership at FutureMeds.  

This trajectory provides her with an unusually comprehensive view of the operational challenges facing sites, as well as good visibility into CROs, Sponsors’ site- and patient-level challenges and the importance of strong collaborations with a wide spectrum of healthcare partners. 

“The BVMA has always impressed me with its ability to combine industry expertise with practical solutions. My career has been shaped by close work with study teams, investigators, CROs, and Sponsors, and I intend to contribute that on-the-ground perspective to the Board. In this role, I act on behalf of the association and its members,not any individual organisation. Strengthening Germany as a research location is a shared responsibility, and it requires coordinated effort across the entire sector.” 

- Ninon Armbrust, Managing Director at FutureMeds Germany & BVMA Board Member 

FutureMeds congratulates Ninon on this achievement and fully supports her contribution to an association that plays an important role in strengthening the German research landscape. 

Photo Curtesy of Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA)